Akoya Biosciences Inc (AKYA)
3.82
+0.01
(+0.26%)
USD |
NASDAQ |
Apr 25, 16:00
3.82
0.00 (0.00%)
After-Hours: 16:51
Akoya Biosciences Total Assets (Quarterly): 180.37M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 180.37M |
| September 30, 2023 | 177.24M |
| June 30, 2023 | 188.88M |
| March 31, 2023 | 154.30M |
| December 31, 2022 | 176.03M |
| September 30, 2022 | 176.46M |
| June 30, 2022 | 184.26M |
| Date | Value |
|---|---|
| March 31, 2022 | 187.13M |
| December 31, 2021 | 190.91M |
| September 30, 2021 | 195.41M |
| June 30, 2021 | 206.34M |
| March 31, 2021 | 74.48M |
| December 31, 2020 | 77.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
74.48M
Minimum
Mar 2021
206.34M
Maximum
Jun 2021
166.88M
Average
180.37M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Bruker Corp | 4.250B |
| Azenta Inc | 2.824B |
| Harvard Bioscience Inc | 137.37M |
| Bionano Genomics Inc | 214.40M |
| Singular Genomics Systems Inc | 265.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 126.60M |
| Shareholders Equity (Quarterly) | 53.77M |
| Debt to Equity Ratio | 1.400 |
| Current Ratio | 3.446 |
| Net Debt Paydown Yield | -1.88% |